HomeInsightsPE

Valiant Laboratories Ltd PE Ratio

Valiant Laboratories Ltd PE Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Dec 9, 2024)

stocks purchased

29.0 K

Stocks Traded

(Dec 9, 2024)

Last Updated on: Dec 09, 2024

Image

Valiant Laboratories Ltd

NSE: VALIANTLAB

PE

-

Last updated on: Dec 09, 2024

Key Highlights

  • The P/E Ratio of Valiant Laboratories Ltd is 0 as of 09 Dec 13:28 PM .
  • The P/E Ratio of Valiant Laboratories Ltd changed from 2080 on March 2024 to 2080 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Valiant Laboratories Ltd is ₹ 124.45 as of 09 Dec 13:23 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Valiant Laboratories Ltd

No data available

Company Fundamentals for Valiant Laboratories Ltd

No data available

Image

Valiant Laboratories Ltd

NSE: VALIANTLAB

Share Price

₹ 124.45

5.40 (4.54%)

stock direction

Last updated on: Dec 09, 2024

Market Price of Valiant Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Valiant Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 2024119.05
05 Dec 2024116.5
04 Dec 2024116.2
03 Dec 2024115.7
02 Dec 2024115.85
29 Nov 2024116.1
28 Nov 2024116.85
27 Nov 2024118.05
26 Nov 2024111.35
25 Nov 2024112.9

SWOT Analysis Of Valiant Laboratories Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Valiant Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Valiant Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Valiant Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Valiant Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Valiant Laboratories Ltd

No data available

* All values are in %

About Valiant Laboratories Ltd

  • Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s.
  • Bharat Chemicals' through Deed of Partnership dated October 17, 1980.
  • The said Partnership Firm, M/s.
  • Bharat Chemicals thereafter converted into a Public Limited Company with the name 'Valiant Laboratories Limited' through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies. The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol.
  • The Company gradually, commenced manufacturing of Paracetamol by late 1982.

Valiant Laboratories Ltd News Hub

News

Valiant Laboratories reports consolidated net loss of Rs 0.51 crore in the June 2024 quarter

Net loss of Valiant Laboratories reported to Rs 0.51 crore in the quarter ended June 2024 ...

Read more

2024-08-13 00:00:00

News

Valiant Laboratories to conduct board meeting

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 Au...

Read more

2024-08-09 00:00:00

News

Valiant Laboratories to conduct board meeting

Valiant Laboratories will hold a meeting of the Board of Directors of the Company on 12 No...

Read more

2024-11-08 00:00:00

News

Valiant Laboratories reports consolidated net loss of Rs 4.74 crore in the September 2024 quarter

Net loss of Valiant Laboratories reported to Rs 4.74 crore in the quarter ended September ...

Read more

2024-11-13 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Valiant Laboratories Ltd

What is the current PE Ratio of Valiant Laboratories Ltd?

The Current PE Ratio of Valiant Laboratories Ltd is 0.0 as on 9 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 9 Dec 2024.

What was the PE Ratio of Valiant Laboratories Ltd last year?

The PE Ratio of Valiant Laboratories Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Valiant Laboratories Ltd indicate about its stock?

The PE Ratio of Valiant Laboratories Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Valiant Laboratories Ltd.

What is the PE Ratio Growth of Valiant Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Valiant Laboratories Ltd grew by -% whereas, the EPS ratio grew by 738.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions